Hormonal therapy in angiodysplasia: Should we completely abandon its use? [1] (multiple letters)

Gastroenterology

Volumn 123, Issue 6, 2002, Pages 2156-2157

  Madanick, Ryan D ^a   Barkin, Jamie S ^a   Junquera, Félix ^b   Saperas, Esteban ^b   Piqué, Josep M ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Institut de Malalties Digestives   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; GESTAGEN;

ANGIODYSPLASIA; CLINICAL ARTICLE; CLINICAL RESEARCH; DOSE RESPONSE; GASTROINTESTINAL DISEASE; HORMONAL THERAPY; HUMAN; LETTER; LIVER CIRRHOSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SAMPLING;

EID: 0036893623     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.37298     Document Type: Article

References (5)

1. F Junquera F Feu M Papo S Videla JR Armengol M Bordas E Saperas JM Piqué J-R. Malagelada A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia Gastroenterology 121 2001 1073 1079
2. JS Barkin BS. Ross Medical therapy for chronic gastrointestinal bleeding of obscure origin Am J Gastroenterol 93 1998 1250 1254
3. E Van Cutsem P Rutgeerts G. Vantrappen Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone Lancet 335 1990 953 955
4. MH Bronner MB Pate JT Cunningham Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure Ann Intern Med 105 1986 371 374
5. E Van Cutsem P Rutgeerts G Coremans Dose-response study of hormonal therapy in bleeding gastrointestinal vascular malformations Gastroenterology 104 1993 A286 (abstr)